Enzymatica’s mouth spray to be launched in Turkey
4 April 2022 Non-regulatory press release Enzymatica’s mouth spray to be launched in Turkey Enzymatica’s mouth spray against the common cold will be launched in Turkey, following the approval as a medical device in the country. This opens a new market of more than 80 million consumers. The Turkish cough and cold market has an estimated worth of approximately EUR 1.1 billion and has shown a steady growth during the last years. Now Enzymatica’s mouth spray against the common cold will be launched in Turkey, following the approval as a medical device by TITCK, the